Analyst coverage & recommendations
Please find below the coverage from independent analysts who follow Oncodesign’ shares. Their recommendation and “Target Price” dates are given as of date and are in force until their next rating is issued.
[Webinar] How to better optimize an oncology drug discovery program
Register for this webinar discussing how conventional and innovative integrated technological skills should be incorporated into an oncology program.
Read more 
